Belviq Makers Engaged in Global Settlement Discussions in State, Federal Cancer Actions



DOCUMENTS
  • Order


OCALA, Fla. — A Florida federal judge has stayed a Belviq breast cancer action until August, explaining the parties are engaged in global settlement discussions and a stay will conserve judicial resources and mitigate discovery costs.

According to the May 6 order issued by Judge Anne C. Conway of the U.S. District Court for the Middle District of Florida, Eisai Inc. and Arena Pharmaceuticals are negotiating settlements of other Belviq cases pending in various state and federal courts.

After taking the weight loss drug for four years, Colleen Scala developed breast cancer. She sued Eisai and Arena, asserting a claim …






UPCOMING CONFERENCES




HarrisMartin's MDL Conference: Recalled Infant Formula and Gardasil

May 25, 2022 - Pittsburgh, PA
The Omni William Penn Hotel

MORE DETAILS



HarrisMartin's New Jersey Asbestos Litigation Conference

June 13, 2022 - New Brunswick, NJ
Hyatt Regency New Brunswick

MORE DETAILS